04.07.2016
- The US Food and Drug Administration has approved Gilead Sciences’ combination pill Epclusa, the first to treat all major forms of hepatitis C. This is the latest in a series of...
01.06.2016
- The European Commission has approved a subcutaneous formulation of Roche’s MabThera for chronic lymphocytic leukemia (CLL) which saves time and eases the treatment burden compared...
